Browsing: Volume 2 Issue 7 – July 2026

General pace of activity picking up after slow first quarter of 2026.

Continued improvements in organ transplant techniques and procedures are increasing the success rate and post-operation life expectancy.

Complexity in modelling cash flows and risks in longevity-linked assets means challenges for asset managers looking to source capital from US insurers.

Longevity and Mortality Investor’s Editor’s Letter for the July 2026 issue.

Pension Schemes Act will codify the operating rules and expectations of superfunds in the UK’s pensions industry.

UK regulator the Financial Conduct Authority is currently conducting a later life lending market study which will be published later this year.

By investing in strong operational foundations today, the pensions industry can move from reacting to policy change to shaping how it is delivered.

James Westerlind, Partner at ArentFox Schiff, dissects the landscape of estate litigation risk in the life settlement market.